Patent
Anti-angiogenic compositions and methods of use
William L. Hunter,Lindsay S. Machan,A. Larry Arsenault +2 more
- 19 Jul 1994
1.2K
TL;DR: In this article, an anti-angiogenic factor and a polymeric carrier were used for embolization of blood vessels and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
read more
Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Nanoparticulate compositions of angiogenesis inhibitors
Elaine Merisko-Liversidge,H. William Bosch,Greta G. Cary,John D. Pruitt,Tuula Ryde,Rajeev A. Jain,Amy Walters +6 more
- 20 Mar 2003
TL;DR: In this paper, the authors describe a class of nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least surface stabilizer, with an average particle size of less than about 2000 nm.
81
Patent
System and method for coating a tubular implantable medical device
Stephen D. Pacetti,Hung Manh Le +1 more
- 07 Oct 2003
TL;DR: In this paper, a system and method for coating a tubular implantable medical device, such as a stent, is described, which can be applied to a variety of applications.
80
Patent
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
Stephen D. Pacetti,Syed F. A. Hossainy +1 more
- 11 Apr 2006
TL;DR: A polymer coating for medical devices based on polyorthoesters and methods for fabricating the coating are described in this paper, where the authors also present a method for manufacturing the polyorthoelectric material.
80
Patent
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
Lixiao Wang
- 19 Nov 2007
TL;DR: In this paper, a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis and chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia, is presented.
80
Patent
Fiber reinforced composite stents
Bin Huang,David C. Gale +1 more
- 01 Aug 2006
TL;DR: Polymeric composite stents reinforced with fibers for implantation into a bodily lumen are disclosed in this paper, where they are used for medical applications such as pacemaker implantation.
80
References
The pathogenesis of atherosclerosis: a perspective for the 1990s
TL;DR: The ability to control the expression of genes encoding these molecules and to target specific cell types provides opportunities to develop new diagnostic and therapeutic agents to induce the regression of the lesions and, possibly, to prevent their formation.
11.4K
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
TL;DR: It is shown that vascular endothelial growth factor (VEGF) probably functions as a hypoxia-inducible angiogenic factor and is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci and the clustering of capillaries alongside VEGF-producing cells.
4.9K
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
Patrick W. Serruys,P. de Jaegere,Ferdinand Kiemeneij,Carlos Macaya,Wolfgang Rutsch,Gr. Heyndrickx,H. Emanuelsson,Jean Marco,Victor Legrand,P. Materne +9 more
TL;DR: The clinical and angiographic outcomes were better in patients who received a stent than in those who received standard coronary angioplasty, however, this benefit was achieved at the cost of a significantly higher risk of vascular complications at the access site and a longer hospital stay.
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
David L. Fischman,Martin B. Leon,Donald S. Baim,Richard A. Schatz,Michael P. Savage,Ian M. Penn,Katherine D. Detre,Lisa Veltri,Donald R. Ricci,Masakiyo Nobuyoshi,Michael W. Cleman,Richard R. Heuser,David Almond,Paul S. Teirstein,R. David Fish,Antonio Colombo,Jeffrey C. Brinker,Jeffrey Moses,Alex Shaknovich,John N. Hirshfeld,Stephen Bailey,Stephen E. Ellis,Randal Rake,Sheldon Goldberg +23 more
TL;DR: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Donald R. Senger,Stephen J. Galli,Ann M. Dvorak,Carole A. Perruzzi,V. Susan Harvey,Harold F. Dvorak +5 more
TL;DR: Tumor ascites fluids from guinea pigs, hamsters, and mice contain activity that rapidly increases microvascular permeability, and this activity is secreted by these tumor cells and a variety of other tumor cell lines in vitro.
4.2K
Related Papers (5)
Ni Ding,Michael N. Helmus +1 more
- 19 Jun 1998
Eric P. Berg,Ronald J. Tuch,Michael Dror,Rodney G. Wolff +3 more
- 07 Jun 1995